Dr. William Levine

William is the founder of Izun Pharmaceuticals Corp, an Israeli biopharmaceutical company that specializes in botanical medicine. This area of specialty pharma develops pharmaceutical and healthcare products from plant-based sources. William subsequently applied his knowledge of botanicals to cannabis and established CannRx Technologies. He serves as CSO for CannRx, where he has helped to develop […]

Read More… from Dr. William Levine

Melissa Diaz

Melissa is a co-founder and the CFO of Arizona-based Rebel Rock, which provides cannabis businesses in North American with specialty accounting solutions, income tax services and business system implementation. In this role, she guides companies through GAAP compliance, financial modeling and general financial accounting functions. Prior to this, Melissa was in charge of overseeing global […]

Read More… from Melissa Diaz

Dr. Constantin von der Groeben

Constantin is managing director and a co-founder of Demecan, a Berlin-based company whose subsidiaries focus on the cultivation, importation and wholesale of medical cannabis. He is well-versed in the regulatory framework of medical cannabis, including European Union-Good Manufacturing Practice, narcotics and pharmaceutical law. Constantin previously worked as an attorney at law firms in Berlin, London […]

Read More… from Dr. Constantin von der Groeben

Glenn Sammis

Glenn consults and advises on all aspects of science at British Columbia-based Complex Biotech Discovery Ventures, including separation, extraction and molecular synthesis. He has built an internationally recognized research group focused on the development of novel synthetic methods for the preparation of natural products and pharmaceuticals. Glenn also serves as an associate professor in the […]

Read More… from Glenn Sammis

Michael Prytz

Michael serves as senior advisor at the Danish Consulate in Toronto where he has been instrumental in helping Canadian and US based companies understand the value Denmark can bring to their European expansion plans. Denmark has received more than 300 Million USD in direct foreign investment to build out GACP cultivation and EU-GMP contract extraction […]

Read More… from Michael Prytz

Peter Homberg

A partner in Dentons’ Berlin office, Peter heads up the law firm’s European Cannabis Group as well as the Life Sciences Practice. He specializes in intellectual property, corporate law and mergers and acquisitions in the life sciences and high-tech sectors. Peter also invests in startup businesses in the life sciences and high-tech fields. Before joining […]

Read More… from Peter Homberg

Darren Bondar

Under Darren’s leadership, Spiritleaf and its parent company, Inner Spirit Holdings, is moving into the adult-use cannabis industry in Canada. Alberta-based Spiritleaf currently has more than 100 corporate and franchised retail outlets under development as well as a portfolio of proprietary brands. The company is the first to be accepted as a member of the […]

Read More… from Darren Bondar

Jessica Billingsley

Jessica  is a technology pioneer, solutions creator and industry leader whose company provides proven software solutions to the emerging cannabis market. As the co-founder and CEO of MJ Freeway, she was a pacesetter who saw the importance of technology as it relates to the cannabis industry. As CEO of Akerna, Jessica’s mission is to drive […]

Read More… from Jessica Billingsley

John Zamparo

As an institutional equity research analyst with CIBC Capital Markets – a subsidiary of the Canadian Imperial Bank of Commerce – John provides research coverage for the cannabis space as well as Canadian retailers and consumer products businesses. John, a director with the firm, was the primary author of CIBC reports titled “Cannabis: Almost Showtime” […]

Read More… from John Zamparo

Alexandra Curley

Alexandra leads the insights and analytics team from Prohibition Partners’ Dublin office and provides market data and intelligence to key stakeholders in the cannabis industry. She is a go-to source for the international media seeking key forecasts for the global cannabis market. Alexandra has worked for some of the world’s largest research houses and also […]

Read More… from Alexandra Curley

Christelle Gedeon

Christelle has spent her entire career in the life sciences and pharmaceutical industry, which has positioned her as a leader in navigating product approvals and licensing, clinical trials and overall intellectual property portfolio management. Before joining Ontario, Canada-based global cannabis company Aphria, Christelle was a partner at Fasken Martineau DuMoulin, an international business law firm […]

Read More… from Christelle Gedeon

Vijay Sappani

Vijay Sappani is a successful diversified cannabis entrepreneur and angel investor in several cannabis startups. His boutique investment and advisory services firm, which is focused on cannabis, medical devices and the health-care sector, currently has several investments in and works in an advisory capacity with cannabis companies in Europe, Asia, Africa and Latin America. Vijay […]

Read More… from Vijay Sappani

Brian Sheng

Brian’s focus at Asia Horizons Cannabis is on international investments, particularly the emerging marijuana sector in Asia. He also is a general partner in Arcview Ventures, the venture arm of The Arcview Group. Before entering the cannabis space, Brian founded Fresh VC – an early stage investment firm where he focused on frontier technologies – […]

Read More… from Brian Sheng

Jonathan Zaid

Jonathan is recognized as an expert on cannabis policy, education and advocacy. He currently oversees the development and implementation of Aurora Cannabis’ global Corporate Social Responsibility and advocacy initiatives. Before joining Aurora, Jonathan founded Canadians for Fair Access to Medical Marijuana, a nonprofit advocacy organization for cannabis patients. He served as the organization’s executive director […]

Read More… from Jonathan Zaid